FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039215306> ?p ?o ?g. }

• W2039215306 endingPage "752" @default.
• W2039215306 startingPage "744" @default.
• W2039215306 abstract "Human breast cancer cells secrete a number of autocrine peptides which modulate their proliferation rates. The known effects of steroid hormones on breast cancer cell proliferation may be mediated in part by altering the production of these growth factors and/or their interactions with cellular receptor sites. Receptors for epidermal growth factor (EGF), which also bind the autocrine growth factor, alpha-transforming growth factor, are present on a number of breast cancer cell lines and it has previously been shown that T-47D and MCF-7 cells respond to progestins with an increase in the concentration of EGF receptors (EGF-R). In the present study we examined the effects of both progestins and glucocorticoids on EGF binding in 10 human breast cell lines. Five of these lines were progesterone receptor positive and all lines expressed the glucocorticoid receptor (GR). All cell lines were initially incubated for 24 hr with increasing concentrations of the synthetic progestin, medroxyprogesterone acetate (MPA), and the level of specifically bound EGF was determined. An increase in specific binding of EGF was confirmed in two PR-positive lines but, in addition, increases in EGF binding were observed in 4 PR-negative cell lines. In these last lines the synthetic glucocorticoid, dexamethasone, was a more potent inducer of EGF binding than MPA, a known glucocorticoid agonist, while the high-affinity PR ligand, ORG 2058, was without effect. Furthermore, MPA competed with dexamethasone for binding to GR in these cell lines, supporting the view that the induction of EGF binding by MPA in these cells was mediated via the GR. This conclusion was further supported by studies in which addition of the glucocorticoid and progestin antagonist, RU 486, inhibited the effect of ORG 2058 in two cell lines and completely abrogated the effect of dexamethasone in two other lines. Detailed binding studies revealed that the increase in EGF binding was accompanied by an increase in the concentration of EGF-R. This effect was observed when EGF binding was assayed at either 0 degree or 37 degrees C. Further studies demonstrated that the increases in EGF binding following ORG 2058 and dexamethasone treatment were accompanied by increases in EGF-R mRNA levels. Our data illustrate that the binding of EGF by some human breast cancer cells can be regulated by both progestins and glucocorticoids acting via their respective receptors and inducing increases in EGF-R mRNA levels." @default.
• W2039215306 created "2016-06-24" @default.
• W2039215306 creator A5001667624 @default.
• W2039215306 creator A5014997892 @default.
• W2039215306 creator A5027248689 @default.
• W2039215306 creator A5030301419 @default.
• W2039215306 creator A5049419140 @default.
• W2039215306 creator A5062144279 @default.
• W2039215306 creator A5078491502 @default.
• W2039215306 date "1989-10-15" @default.
• W2039215306 modified "2023-09-26" @default.
• W2039215306 title "Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines" @default.
• W2039215306 cites W1967605182 @default.
• W2039215306 cites W1971663675 @default.
• W2039215306 cites W1973071934 @default.
• W2039215306 cites W1979224484 @default.
• W2039215306 cites W1983649348 @default.
• W2039215306 cites W1993344738 @default.
• W2039215306 cites W1995434642 @default.
• W2039215306 cites W1998507980 @default.
• W2039215306 cites W2001397706 @default.
• W2039215306 cites W2010394496 @default.
• W2039215306 cites W2015811901 @default.
• W2039215306 cites W2016580215 @default.
• W2039215306 cites W2019691808 @default.
• W2039215306 cites W2026989222 @default.
• W2039215306 cites W2036531069 @default.
• W2039215306 cites W2049832377 @default.
• W2039215306 cites W2055137307 @default.
• W2039215306 cites W2060333964 @default.
• W2039215306 cites W2068961038 @default.
• W2039215306 cites W2073865988 @default.
• W2039215306 cites W2080066625 @default.
• W2039215306 cites W2114187408 @default.
• W2039215306 cites W2114627940 @default.
• W2039215306 cites W2138696906 @default.
• W2039215306 cites W2153837633 @default.
• W2039215306 cites W2272253461 @default.
• W2039215306 cites W49764483 @default.
• W2039215306 doi "https://doi.org/10.1002/ijc.2910440432" @default.
• W2039215306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2793247" @default.
• W2039215306 hasPublicationYear "1989" @default.
• W2039215306 type Work @default.
• W2039215306 sameAs 2039215306 @default.
• W2039215306 citedByCount "50" @default.
• W2039215306 countsByYear W20392153062014 @default.
• W2039215306 countsByYear W20392153062015 @default.
• W2039215306 countsByYear W20392153062017 @default.
• W2039215306 countsByYear W20392153062021 @default.
• W2039215306 countsByYear W20392153062022 @default.
• W2039215306 crossrefType "journal-article" @default.
• W2039215306 hasAuthorship W2039215306A5001667624 @default.
• W2039215306 hasAuthorship W2039215306A5014997892 @default.
• W2039215306 hasAuthorship W2039215306A5027248689 @default.
• W2039215306 hasAuthorship W2039215306A5030301419 @default.
• W2039215306 hasAuthorship W2039215306A5049419140 @default.
• W2039215306 hasAuthorship W2039215306A5062144279 @default.
• W2039215306 hasAuthorship W2039215306A5078491502 @default.
• W2039215306 hasConcept C126322002 @default.
• W2039215306 hasConcept C128240485 @default.
• W2039215306 hasConcept C134018914 @default.
• W2039215306 hasConcept C170493617 @default.
• W2039215306 hasConcept C2775960820 @default.
• W2039215306 hasConcept C2776362946 @default.
• W2039215306 hasConcept C2776888042 @default.
• W2039215306 hasConcept C2780841215 @default.
• W2039215306 hasConcept C54355233 @default.
• W2039215306 hasConcept C55493867 @default.
• W2039215306 hasConcept C59493245 @default.
• W2039215306 hasConcept C62112901 @default.
• W2039215306 hasConcept C71315377 @default.
• W2039215306 hasConcept C71924100 @default.
• W2039215306 hasConcept C81885089 @default.
• W2039215306 hasConcept C86803240 @default.
• W2039215306 hasConceptScore W2039215306C126322002 @default.
• W2039215306 hasConceptScore W2039215306C128240485 @default.
• W2039215306 hasConceptScore W2039215306C134018914 @default.
• W2039215306 hasConceptScore W2039215306C170493617 @default.
• W2039215306 hasConceptScore W2039215306C2775960820 @default.
• W2039215306 hasConceptScore W2039215306C2776362946 @default.
• W2039215306 hasConceptScore W2039215306C2776888042 @default.
• W2039215306 hasConceptScore W2039215306C2780841215 @default.
• W2039215306 hasConceptScore W2039215306C54355233 @default.
• W2039215306 hasConceptScore W2039215306C55493867 @default.
• W2039215306 hasConceptScore W2039215306C59493245 @default.
• W2039215306 hasConceptScore W2039215306C62112901 @default.
• W2039215306 hasConceptScore W2039215306C71315377 @default.
• W2039215306 hasConceptScore W2039215306C71924100 @default.
• W2039215306 hasConceptScore W2039215306C81885089 @default.
• W2039215306 hasConceptScore W2039215306C86803240 @default.
• W2039215306 hasIssue "4" @default.
• W2039215306 hasLocation W20392153061 @default.
• W2039215306 hasLocation W20392153062 @default.
• W2039215306 hasOpenAccess W2039215306 @default.
• W2039215306 hasPrimaryLocation W20392153061 @default.
• W2039215306 hasRelatedWork W1993766425 @default.
• W2039215306 hasRelatedWork W1999156064 @default.
• W2039215306 hasRelatedWork W2031062169 @default.

• next